Ironwood Pharmaceuticals IRWD Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's income tax?
- Ironwood Pharmaceuticals (IRWD) reported income tax of $24.4M in Q1 2026.
- How has Ironwood Pharmaceuticals's income tax changed year-over-year?
- Ironwood Pharmaceuticals's income tax increased by 2090.2% year-over-year, from $1.11M to $24.4M.
- What is the long-term trend for Ironwood Pharmaceuticals's income tax?
- Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's income tax has grown at a -39.0% compound annual growth rate (CAGR), from -$332.67M to $46.01M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.